Authors may opt to publish their research under an open access license in any of the AACR hybrid journals. The hybrid AACR journals include: Blood Cancer Discovery; Cancer Discovery; Cancer ...
Cancer Res (2023) 83 (8_Supplement): LB031.
Abramson Cancer Center, Department of Medicine, Perelman School of Medicine, ...
Cancer Res (2018) 78 (13_Supplement): 4542. Introduction: Liquid biopsy-based detection and monitoring of tumor-specific somatic mutations in cell-free DNA has great potential to improve patient care ...
Abstract. Binding of steroid hormones to their cognate receptors regulates the growth of most prostate and breast cancers. We hypothesized that CYP11A inhibition might halt the synthesis of all ...
1Department of Oncology, University of Lausanne, Lausanne, Switzerland.
1Yonsei University, College of Medicine, Seoul, Republic of Korea.
1Department of Oncology, Mayo Clinic, Rochester, Minnesota.
Cancer Res (2025) 85 (8_Supplement_2): ND11.
The combination of anti-TROP2 ADCs with PD-(L)1 inhibitors represents a promising therapeutic strategy, merging targeted therapy with immunotherapy to improve treatment outcomes. Clinical trials are ...
IL1R2 in both macrophages and breast cancer cells orchestrates an immunosuppressive tumor microenvironment by upregulating PD-L1 expression and can be targeted to enhance the efficacy of anti-PD-1 in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results